mephyton- phytonadione tablet
bausch health us llc - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 5 mg - mephyton is indicated for the treatment of adults with the following coagulation disorders which are due to faulty formation of factors ii, vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity. mephyton is contraindicated in patients with a history of a hypersensitivity reaction to phytonadione or inactive ingredients [see description (11)] . risk summary published studies with the use of phytonadione during pregnancy have not reported a clear association with phytonadione and adverse developmental outcomes [see data]. there are maternal and fetal risks associated with vitamin k deficiency during pregnancy [see clinical considerations]. animal reproduction studies have not been conducted with phytonadione. the estimated background risk for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinica
phytonadione injection, emulsion
international medication systems, limited - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 1 mg in 0.5 ml - phytonadione injectable emulsion, usp is indicated for the treatment of the following coagulation disorders which are due to faulty formation of factors ii, vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity: • anticoagulant-induced hypoprothrombinemia caused by coumarin or indanedione derivatives; • hypoprothrombinemia due to antibacterial therapy; • hypoprothrombinemia secondary to factors limiting absorption or synthesis of vitamin k, e.g., obstructive jaundice, biliary fistula, sprue, ulcerative colitis, celiac disease, intestinal resection, cystic fibrosis of the pancreas, and regional enteritis; • other drug-induced hypoprothrombinemia where it is definitely shown that the result is due to interference with vitamin k metabolism, e.g., salicylates. phytonadione injectable emulsion, usp is indicated for prophylaxis and treatment of vitamin k-deficiency bleeding in neonates. hypersensitivity to phytonadione or any other component of this medication [see warnings a
phytonadione injection, emulsion phytonadione injection, emulsion
teligent pharma, inc. - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 2 mg in 1 ml - phytonadione is indicated for the treatment of the following coagulation disorders which are due to faulty formation of factors ii, vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity: - anticoagulant-induced hypoprothrombinemia caused by coumarin or indanedione derivatives; - hypoprothrombinemia due to antibacterial therapy; - hypoprothrombinemia secondary to factors limiting absorption or synthesis of vitamin k, e.g., obstructive jaundice, biliary fistula, sprue, ulcerative colitis, celiac disease, intestinal resection, cystic fibrosis of the pancreas, and regional enteritis; - other drug-induced hypoprothrombinemia where it is definitely shown that the result is due to interference with vitamin k metabolism, e.g., salicylates. phytonadione is indicated for prophylaxis and treatment of vitamin k-deficiency bleeding in neonates. hypersensitivity to phytonadione or any other component of this medication. [see warnings and precautions (5.1)]. risk summary phytonadione c
mephyton- phytonadione tablet
rebel distributors corp - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 5 mg - mephyton is indicated in the following coagulation disorders which are due to faulty formation of factors ii, vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity. mephyton tablets are indicated in: - anticoagulant-induced prothrombin deficiency caused by coumarin or indanedione derivatives; - hypoprothrombinemia secondary to antibacterial therapy; - hypoprothrombinemia secondary to administration of salicylates; - hypoprothrombinemia secondary to obstructive jaundice or biliary fistulas but only if bile salts are administered concurrently, since otherwise the oral vitamin k will not be absorbed. hypersensitivity to any component of this medication.
mephyton- phytonadione tablet
physicians total care, inc. - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 5 mg - mephyton is indicated in the following coagulation disorders which are due to faulty formation of factors ii,vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity. mephyton tablets are indicated in: hypersensitivity to any component of this medication.
phytonadione injection, emulsion
general injectables & vaccines, inc - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 1 mg in 0.5 ml - 1.1 treatment of hypoprothrombinemia due to vitamin k deficiency or interference phytonadione injectable emulsion, usp is indicated for the treatment of the following coagulation disorders which are due to faulty formation of factors ii, vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity; - anticoagulant-induced hypoprothrombinemia caused by coumarin or indanedione derivatives; - hypoprothrombinemia due to antibacterial therapy; - hypoprothrombinemia secondary to factors limiting absorption or synthesis of vitamin k, e.g., obstructive jaundice, biliary fistula, sprue, ulcerative colitis, celiac disease, intestinal resection, cystic fibrosis of the pancreas, and regional enteritis; - other drug-induced hypoprothrombinemia where it is definitely shown that the result is due to interference with vitamin k metabolism, e.g., salicylates. 1.2 prophylaxis and treatment of vitamin k-deficiency bleeding in neonates phytonadione injectable emulsion, usp is indicated for prophylaxi
mephyton- phytonadione tablet
carilion materials management - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 5 mg - mephyton is indicated in the following coagulation disorders which are due to faulty formation of factors ii,vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity. mephyton tablets are indicated in: hypersensitivity to any component of this medication.
phytopharma dragées pour les veines/venen dragées phytopharma dragées pour les veines/venen dragées
phytopharma s.a. - hippocastani extrait ethanolicum sec - phytopharma dragées pour les veines/venen dragées - hippocastani extrait ethanolicum sec 200 mg corresp. aescinum 40 mg, der: 5-6.5:1, excipiens pro compresso de la brume. - en cas de troubles veineux - phytoarzneimittel
phytopharma blasen dragées phytopharma bulles dragées
phytopharma s.a. - betulae folii extrait aquosum raisins secs ours folii extrait aquosum sec, equiseti extrait aquosum sec, ononidis l'extrait de racine de ethanolicum sec - phytopharma bulles dragées - betulae folii extrait aquosum sec 40 mg corresp. flavonoidea 0,8 mg, der: 4.0-8.0:1, le raisin d'ours folii extrait aquosum sec 80 mg corresp. arbutinum 8 mg, der: 2.8-4.2:1, equiseti extrait aquosum sec 40 mg, der: 4-7:1, ononidis l'extrait de racine de ethanolicum sec 40 mg, der: 4-9:1, auszugsmittel ethanolum 30 % v/v, sont, excipiens pro compresso de la brume. - lors de blasenbeschwerden - phytoarzneimittel
phytopharma harpago phytopharma harpago
phytopharma s.a. - harpagophyti radicis pulvis - phytopharma harpago - harpagophyti poudre de racine de 182.36 mg, excipiens pro compresso. - traitement d’appoint des douleurs légères dues aux signes d’usure de l’appareil locomoteur - phytoarzneimittel